The Oxford International Diabetes Summit: Implications of the DAWN study: 7-8 April 2002, Oxford, UK

Practical Diabetes International

Volumn 19, Issue 6, 2002, Pages 187-192

  Roglic, Gojka ^a   Matthews, David ^b   Rubin, Richard R ^c   Bech, Ole Molskov ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; PLACEBO;

AWARENESS; BEHAVIOR THERAPY; BLINDNESS; CLINICAL RESEARCH; CLINICAL TRIAL; COMPUTER SYSTEM; CONFERENCE PAPER; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DOCTOR PATIENT RELATION; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE QUALITY; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; LIFESTYLE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PERCEPTION; PHYSICIAN ATTITUDE; POLITICAL SYSTEM; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIMARY HEALTH CARE; PSYCHOSOCIAL ENVIRONMENT; RISK FACTOR; SELF CARE; SYMPOSIUM; UNITED KINGDOM; WELLBEING; WORKSHOP;

EID: 0036650074     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.380     Document Type: Conference Paper

References (0)